REGN card
REGN price forecast
Regeneron Pharmaceuticals$952,40
P/E now is 21,0. Average over 5 years: 18,3 (range 15–22). The stock is 15% above its history.
Base · FY2030
$1 542,14+12,4% a year
The base case gives 12,4% a year, above your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$1 542,14+12,4% a year